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SUMMARY – Ocular vestibular evoked myogenic potentials (oVEMP) and cervical VEMP 
(cVEMP) are newer diagnostic methods, which allow an insight into the otolith senses. Our aim was 
to determine changes in certain parameters of the VEMP wave complex after successfully performed 
repositioning procedure, as an indicator of the state of recovery in patients with benign paroxysmal 
positional vertigo (BPPV). Th is may confi rm the theory of otolith returning into the area of otolithic 
senses. Th e study included 48 patients with unilateral posterior semicircular canal BPPV. On their fi rst 
arrival, otoneurological examinations, oVEMP and cVEMP tests were performed. Th e same were 
included in follow up check-ups scheduled at seven days and six months after successful implementa-
tion of Epley maneuvers. Th e initial measurement revealed a signifi cantly reduced amplitude of 
oVEMP on the aff ected side. On the 7-day measurement, the amplitude increase was observed on the 
aff ected side, with signifi cant reduction in the amplitude ratio (p=0.693), which reached statistical 
signifi cance on the last measurement at 6 months (p=0.006). Th ese fi ndings confi rmed the hypothesis 
of the return of otoconia into the utricular area.
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Introduction
Benign paroxysmal positioning vertigo (BPPV) is 
the most common cause of peripheral forms of vertigo1. 
According to various sources, BPPV accounts for 20%-
30% of vertigo cases in the general population, while its 
share in older population rises to more than 50% ac-
cording to some authors. Th is is a growing public health 
problem, as it ever more frequently aff ects the younger, 
active population and greatly infl uences the quality of 
life. Vertigo can also be a symptom of many neurologi-
cal diseases such as multiple sclerosis, and has a nega-
tive impact on the patient health-related quality of 
life2,3. Th e vast majority of patients can be successfully 
treated with Epley repositioning maneuver, which is 
most commonly used in clinical practice when the pos-
terior semicircular canal (PC) is aff ected4-6.
In a cer tain number of patients, there is recurrence 
of the disease after a while, which usually aff ects the 
same semicircular canal. Relapses occur in approxi-
mately 30% of patients after one year7-9. Accordin g to 
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the available literature, Brandt et al. found 50% of re-
currence in their retrospective study on 125 patients, 
six to 17 years subsequent to the diagnosis, 80% of 
which occurred after one year. Th ey recorded almost 
double incidence of relapse in patients in the sixth de-
cade of life as compared with those in the seventh de-
cade. Th e patients that had an eight-year symptom-
free period had no recurrence of the disease after-
wards10.
Otolithi c receptors respond to linear acceleration 
or/and deceleration11, and the hardest challenge for 
clinical practice is to measure linear acceleration in pa-
tie nts in the easiest and safest way.
Vestibular evoked myogenic potentials (VEMP) 
are one of the newer diagnostic methods which allows 
an insight into the otolith senses. Th is diagnostic 
method relies on the fact that the utricle and saccule 
are not only sensitive to linear acceleration, but also to 
loud sound. Th e founder of the idea on the sensitivity 
of vestibular organ to the sound stimuli was the Italian 
physiologist Dr Pietro Tullio (1881-1941). Th e fi rst 
research of the eff ects of sound and vibration on the 
vestibular system in humans was performed by Ribarić 
et al.12. Ocular vestibular evoked myogenic potential 
(oVEMP) refl ect the excitatory utricular response and 
are used to evaluate the ascending vestibular pathway, 
as the crossed vestibulo-ocular refl ex13 pointed to the 
shift of the contralateral eye to sound stimulation of 
the vestibular system14, demonstrating that acoustic 
stimulation of the otoliths leads to oVEMP. However, 
there still are doubts about whether oVEMP records 
changes exclusively in the utriculus or also in the sac-
culus15. Anyway, oVEMP depend on the state of the 
upper part of the vestibular nerve16. Th e utricular sig-
nals are transmitted through the superior vestibular 
nerve to the superior vestibular region in the brain-
stem, crossing to the oculomotor nucleus and to the 
extraocular muscles. Cervical vestibular evoked myo-
genic potentials (cVEMP) assess the descending ves-
tibular pathway as an ipsilateral sacculocollic refl ex17,18. 
Th ey measure saccular function representing inhibito-
ry responses conducted through the inferior vestibular 
nerve to the accessory nucleus in the brainstem and 
via accessory nerves to the ipsilateral sternocleidomas-
toid muscle19. Successful repositioning procedure is 
expected to result in reduction of disease symptoms, 
increase in the peak-to-peak amplitude on the aff ected 
side, leveling with the unaff ected side, as well as lower-
ing of AR after a while because some time is needed 
for otolith embedding in the otolithic membrane.
In the past few years, the number of studies related 
to VEMP and BPPV has increased, as VEMP is the 
only clinical test for vestibular system which provides 
information on otolith function.
Sreenivasan et al.20 conclude that disease pathology 
is indicated as absent response from ipsilateral ear, pro-
longed latency of n23, and decreased peak-to-peak 
amplitude (p13, n23). Hui et al.21 did not analyze the 
latency and amplitude of the waves in c/oVEMP and 
defi ned abnormal c/oVEMP only as absent responses. 
So far, none of the studies has clearly confi rmed which 
parameter of the cVEMP and/or oVEMP wave com-
plex is statistically important for clinical interpretation 
because most studies involved an insuffi  cient number 
of subjects.
Our aim was to determine whether there are 
changes in certain parameters of the VEMP wave 
complex after successfully performed repositioning 




Th is prospective clinical study was performed at 
the Department of Otorhinolaryngology, Vukovar 
General County Hospital. A total of 48 patients with 
unilateral PC-BPPV were included in the study. Pa-
tients with anterior or horizontal canal BPPV, or bilat-
eral BPPV were excluded to standardize the study and 
to include a homogeneous population. Inclusion crite-
rion was a history of short-lasting (≤60 s), positive 
Dix-Hallpike test using Frenzel glasses (vertigo pro-
voked by head position changes relative to gravity). 
Exclusion criteria were any kind of hearing damage, 
unilateral weakness ≥25% and directional preponder-
ance ≥35% in the caloric test, and positive Ménière 
disease or vestibular migraine.
Information was collected during diagnostic evalu-
ation of the patients. All patients underwent standard-
ized otoneurologic examination. Also, audiologic ex-
amination (Pure-tone audiometry, tympanometry), 
entire videonystagmography (VNG) battery, and cer-
vical and ocular VEMP testing were performed.
Th e study was performed in accordance with the 
Helsinki II Declaration. All participants gave their in-
formed consent before inclusion in the study.
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Full videonyst agmography battery was performed 
by the VO425 device (Interacoustics, Assens, Den-
mark).
Th e VEMP was determined using Eclipse Plat-
form (Interacoustics, Assens, Denmark), and electro-
myography (EMG) (System Otoacces, Montreal, 
Canada). Th e acoustic stimulus was made monoaurally 
by Insert earphones ABR 3A (Interacoustics, Assens, 
Denmark), with earplugs (3M Auditory Systems, In-
dianapolis, USA). One type of air-conducted stimuli 
was used, 5.1 ms, 95 dB nhL clicks of negative polarity 
and 500 Hz, 95 dB nhL tone bursts of negative polar-
ity with a linear envelope (2 ms rise/fall time, 1 ms 
plateau). Two hundred sweeps were averaged for each 
test. Th e following values were compared: latencies of 
p and n wave, peak-to-peak amplitudes and amplitude 
ratio (AR) in both groups of subjects, and the relation 
of all measured parameters between the groups.
In the interpretation of VEMP results, we used the 
following parameters: p and n wave latency, peak-to-
peak amplitude size and interneural AR expressed in 
percentages. As a clinically signifi cant parameter, we 
took the absolute value of the peak-to-peak amplitude, 
which is double in size of the other one (AR ≥35%).
Th e fi rst follow up examination after the reposi-
tioning procedure was scheduled after 7 days, with re-
completion of the questionnaire, Dix-Hallpike, VNG, 
cVEMP and oVEMP. Follow up examinations include 
fi lling out the questionnaire and Dix-Hallpike test re-
peated every 7 days (4 times at the most) until negative 
result is recorded. Th e last check-up was scheduled at 
six months after the successful repositioning maneuver 
and consisted of the same procedures and question-
naires as the fi rst one.
Statistical analysis
Descriptive statistics methods were used for de-
scription of the distribution of the frequencies of the 
study variables. All variables were tested for normality 
of distribution with Kolmogorov-Smirnov test, and 
according to the results, parametric or nonparametric 
methods were applied. Th e values of continuous vari-
ables were expressed as arithmetic mean and standard 
deviation for normally distributed variables, and by 
median and range for non-normally distributed vari-
ables. Nominal points were presented with distribu-
tion of the occurrence by groups and percentage.
Student’s T-test was used to determine diff erences 
between two independent samples, while Student’s T-
test for dependable samples was used to determine dif-
ferences between two measurements (Wilcoxon test 
for nonparametric distribution). Analysis of variance 
for repeated measurements (nonparametric Friedman 
test) was used to determine diff erences of dependent 
samples according to the time of measurement (3 and 
more).
Th e Receiver Operating Characteristic (ROC) 
analysis was applied to determine optimal borderline 
values, the area under the ROC curve (AUC), specifi c-
ity and sensitivity of the tested parameters in cases of 
relapse. Th e infl uence of more predictors on the posi-
tive test and on the recurrence was evaluated by logis-
tic regression. Th e level of association was assessed by 
Pearson or Spearman coeffi  cient of correlation, de-
pending on the normality of distribution. Th e χ2-test 
and Fisher exact test were used to determine diff er-
ences between proportions. Th e level of signifi cance 
was set at a=0.05.
Results
Forty-eight patients with typical unilateral BPPV 
were included (33 women, median age 63, range 53-69 
years). In 33 (68.7%) cases, the right side was aff ected. 
All 48 (100%) patients underwent two repositioning 
procedures, while two additional repositioning proce-
dures were required in 16 (33.33%) patients because 
the vertiginous problems persisted and the Dix-Hall-
pike test was still positive. After the last repositioning 
procedure applied, complete withdrawal of symptoms 
and negative Dix-Hallpike test were recorded in all 48 
(100%) patients. Follow up examination at 6 months 
was conducted in all 48 (100%) patients.
cVEMP
In all patients, three were no statistically signifi cant 
changes in the size of p13 latency on the aff ected side 
before and after successful repositioning procedure 
(p=0.203; p=0.310). Th e same applies to the aff ected 
side n23 latency (p=0.646; p=0.946). Th e 6-month fol-
low up showed no signifi cant diff erences in the size of 
latency p13 and n 23 wave either (p<0.950; p=0.599; 
p=0.893; p=0.074).
After successful implementation of the reposition-
ing procedure, there was no signifi cant increase in the 
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Table 1. Median value of the cVEMP peak-to-peak amplitude
cVEMP













After Epley 41.3 (20.92-74.88) 32.02 (20.91-59.35) 0.227
Th ree days after Epley 33.15 (25.08-64.8) 24.26 (14.88-42.13) 0.243
Six months after Epley 37.46 (25.74-84.34) 27.02 (20.46-62.09) 0.065
*Friedman’s test; †Mann Whitney’s U test; cVEMP = cervical vestibular evoked myogenic potentials
Table 2. Mean cVEMP amplitude ratio measured










*Friedman’s test; †Wilcoxon test; cVEMP = cervical vestibular evoked myogenic potentials; AR = amplitude ratio
Table 3. Median value of the oVEMP peak-to-peak amplitude
oVEMP













After Epley 1.61 (1.28-2.67) 1.64 (1.19-2.66) 0.901
Day 3 after Epley 2.21(1.36-3.06) 1.97 (1.22-3.01) 0.710
Month 6 after Epley 2.1 (1.25-3.14) 1.9 (1.03-2.6) 0.600
*Friedman’s test; †Mann Whitney’s U test; oVEMP = ocular vestibular evoked myogenic potentials
Table 4. Mean oVEMP amplitude ratio measured











*Friedman’s test; †Wilcoxon test; oVEMP = ocular vestibular evoked myogenic potentials; AR = amplitude ratio










cVEMP – interaural 
amplitude ratio
6.067 2.387 6.461 0.011 431.5 4.01-46428.7
oVEMP – interaural 
amplitude ratio
10.094 3.172 10.130 0.001 24206.15 48.336-1.21. 107
95% CI = 95% confi dence interval; cVEMP = cervical vestibular evoked myogenic potentials; oVEMP = ocular vestibular evoked myo-
genic potentials
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absolute value of the amplitude either on the aff ected 
or on the unaff ected side. Th e cVEMP amplitude ab-
solute values are shown in Table 1.
Interaural amplitude ratio
On the fi rst measurement, AR ≥35% was recorded 
in half of the 48 patients. After fi rst repositioning pro-
cedure, on the second measurement, the AR <35% was 
found in 26 (54.2%) patients. Th e third measurement 
was performed in 16 (33.33%) patients, where the 
Dix-Hallpike test was positive after the fi rst two failed 
repositioning maneuvers. Th e AR <35% was recorded 
in two (12.5%) patients. At 6-month follow up, 
cVEMP AR <35% was found in 32 (66.7%) patients 
(Table 2).
oVEMP
In all patients, there were no statistically signifi cant 
changes in the size of p15 latency on the aff ected side 
before and after successfully performed repositioning 
procedure (p=0.455; p=0.343). Th e same applies to the 
aff ected side n10 latency (p=0.787; p=0.378). Th e 
6-month follow up showed no signifi cant diff erences 
in the size of latency p15 and n 10 waves either 
(p=0.893; p=0.655; p=0.223; p=0.302).
After successful repositioning procedure, an in-
crease in the absolute value of the amplitude between 
the fi rst and second measurements was recorded on 
the aff ected side. Th e oVEMP amplitude absolute val-
ues are shown in Table 3.
Interaural amplitude ratio
On the fi rst measurement, AR ≥35% with a pre-
ponderance in favor of the aff ected side was recorded 
in 35 (72.9%) patients. On the second measurement, 
after the fi rst repositioning procedure, AR <35% was 
obtained in 22 (45.8%) patients. Th e third measure-
ment, which was conducted in 16 patients that did not 
respond to the fi rst repositioning procedure, AR <35% 
was found in three (18.8%) patients. At 6-month fol-
low up, AR <35% was recorded in 35 (72.9%) patients 
(Table 4).
Recurrence
After six months, vertiginous disturbances that 
matched the symptoms of BPPV recurred in nine 
(18.75%) patients, as confi rmed by positive Dix-Hall-
pike probe. In their fi ndings, there was a statistically 
signifi cant diff erence of cVEMP and oVEMP AR in 
relation to the subjects free from recurrence (p=0.044, 
p<0.001). In patients with recurrence, the latency value 
of p and n wave at cVEMP-and so with oVEMP did 
not change signifi cantly compared to those without 
recurrence at 6-month follow up.
Th e role of test parameters in predicting recurrence 
(logistic regression)
Only nine (18.75%) patients had recurrence. Lo-
gistic regression evaluated the impact of individual 
predictors of the likelihood that they would be ob-
served in patients that developed recurrence. Univari-
ate regression analysis proved the oVEMP and 
cVEMP AR as a signifi cant predictor (Table 5).
As a model, we observed predictors that were sig-
nifi cant (cVEMP AR and oVEMP AR). Th e model 
was completely statistically signifi cant (c2=24.31, 
p<0.001), indicating that patients may diff er according 
to clinical picture. Th e model as a whole explained be-
tween 39.7% (R 2 COX & Snell) and 64.2% (r2Negel-
kerke) of variance for the presence of clinical symptoms 
of recurrence, and accurately classifi ed 81.3% of cases. 
Th e strongest predictor was oVEMP AR (Table 6).
Table 6. Prediction of the likelihood that patients will develop recurrence – univariate regression analysis







cVEMP – interaural 
amplitude ratio 
7.007 3.125 5.028 0.025 1104.49 2.417-504758.95
oVEMP – interaural 
amplitude ratio 
10.663 3.854 7.652 0.006 42726.86 22.376-8.159. 107
Constant -5.571 1.573 12.54 0.000 0.004
95% CI = 95% confi dence interval; cVEMP = cervical vestibular evoked myogenic potentials; oVEMP = ocular vestibular evoked myo-
genic potentials
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Th e role of test parameters in predicting recurrence 
(ROC analysis)
Th e ROC method was selected as a simple way to 
assess diff erences in each indicator according to clini-
cal recurrence and was determined on the basis of 
specifi city and sensitivity.
Th e method of ROC curve that gradually changes 
the cut-off  values diff erentiating subjects with and 
without recurrence was employed to assess the values 
of particular parameters found by logistic regression to 
contribute signifi cantly to the model. Th e cut-off  point 
for a particular group of subjects was changed in order 
to objectively identify, by creating the ROC curve, the 
cut-off  value that would best diff erentiate the groups 
compared. Th e results showed that oVEMP AR was 
the only signifi cant diagnostic indicator of recurrence 
(77.8% sensitivity, 94.9% specifi city, p=0.002) (Table 7, 
Fig. 1).
Discussion
Th is prospective study including 48 patients 
showed an increase in the absolute value of the ampli-
tude of the aff ected ear after the second repositioning 
procedure. Th e increase was considerable but not sta-
tistically signifi cant. We can explain it with a large in-
terquartile range and large average range between 
minimum and maximum. In the unaff ected ear, there 
was no signifi cant increase in the absolute value of the 
amplitude.
A signifi cant increase in the amplitude on the af-
fected side occurred after repositioning procedure at 
oVEMP points to the return of detached otoconia just 
in the area of utricle. After the fi rst repositioning pro-
cedure, there was no increase in the absolute value of 
the amplitude at the aff ected ear. Th e explanation 
might lie in the histologic structure of the cupula utri-
cle. Otoconial mass is made of thousands of otoconia 
and overlaid by an otoconial membrane. Th e upper 
part of the membrane is dense. On the opposite side, 
the lower part is more rigid and leads to linear force 
transduction. Reduced oVEMP is thought to origi-
nate from partial degeneration of the utricular hair 
cells22. Bremova et al.23 measured oVEMP amplitudes 
before and after Epley maneuvers and found signifi -
cant increase in the amplitudes following the maneu-
vers whilst the cVEMPs had no amplitude change. 
Th ese fi ndings support the theory that utricular func-
tion is more damaged than saccular function.
In cVEMPs, no statistically signifi cant increase in 
the absolute value of the amplitude was observed in 
either unaff ected or aff ected ear after the fi rst reposi-
tioning procedure. Th is result suggested that there was 
no change in the saccule function because there was no 
return of otoconia, the presence of which would in-
crease the absolute value of the amplitude. Th is can be 
explained by the anatomical structure of the otolithic 
senses. Th e utricle and saccule are connected with the 
utriculosaccular duct24. Th e mean diameter of the en-
Table 7. ROC curve parameters with regard to clinical recurrence
Parameter Area under the curve 95% CI  Sensitivity Specifi city Cut-off p
AR – cVEMP 0.724 0.576-0.843 66.7 89.7 >0.26 0.082
AR – oVEMP 0.848 0.715-0.935 77.8 94.9 >0.23 0.002
ROC curve = Receiver Operating Characteristic curve; 95% CI = 95% confi dence interval; cVEMP = cervical vestibular evoked myogenic 
potentials; oVEMP = ocular vestibular evoked myogenic potentials; AR = amplitude ratio
Fig. 1. ROC analysis of sensitivity, specifi city 
and borderline values for the parameters observed 
according to clinical recurrence.
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dolymphatic duct is 0.16x0.41 mm at the internal ap-
erture of the vestibular aqueduct and 0.09x0.20 mm at 
the isthmus25. Th e endolymphatic valve allows the en-
dolymph fl ow from the utricle to the saccule, but not 
vice versa26.
From the clinical point of view, oVEMP appears to 
be better suited for testing PC-BPPV than cVEMP27. 
In 33 (68.8%) cases, the right side was aff ected. One of 
the explanations is sleeping habit on the right side in 
most people. In the literature, a higher incidence of 
BPPV of the right labyrinth in relation to the left one 
is reported28.
In 16 (33.3%) patients, the third and fourth reposi-
tioning procedure had to be applied due to persistence 
of vertiginous problems. Following the last reposition-
ing procedure, there was signifi cant improvement and 
even complete withdrawal of symptoms in all 48 
(100%) patients.
In 32 (66.7%) patients, two repositioning maneu-
vers were suffi  cient for signifi cant recovery, allowing 
them to do their usual activities. Complete withdrawal 
of symptoms after the second repositioning procedure 
has also been reported by other authors29,30.
Th e most important parameter for the interpreta-
tion of the results in clinical practice is the interaural 
AR31. We consider AR ≥35% as clinically signifi cant. 
It is interpreted as unilateral damage to the lower part 
of the labyrinth32-34. As a clinically signifi cant param-
eter, we take the absolute value of the peak-to-peak 
amplitude, which is double in size of the other one.
Th e BPPV has a profound eff ect on function, inde-
pendence and health-related quality of life. Beyond 
the unpleasant sensation of vertigo, BPPV negatively 
aff ects balance and increases the risk of falling35. As 
vertiginous disturbances negatively aff ect the health-
related quality of life, we decided to examine which 
parameter of the oVEMPs (the only vestibular test 
that refl ects utricle function) could indicate an in-
creased likelihood of BPPV recurrence. Th e ROC 
method was selected as a simple way to assess diff er-
ences in each indicator according to clinical recur-
rence; is determined on the basis of specifi city and 
sensitivity. Our results are diff erent from those report-
ed by Lee et al.36 on a higher incidence of cVEMP 
abnormality in recurrent compared with non-recurrent 
BPPV cases. Zhou et al.37 found signifi cant diff erence 
in the abnormal rate on oVEMP test between the re-
current and non-recurrent groups (p<0.01) but not in 
cVEMP (p>0.05). So far, there is no study providing 
the wave complex parameters or cut-off  value of 
cVEMP or oVEMP wave parameters that would point 
to the increased likelihood of recurrence.
According to our results, the oVEMP AR was the 
only signifi cant diagnostic predictor of recurrence. Th e 
AR greater than 23% could indicate an increased inci-
dence of vertiginous disturbances in patients. On fol-
low up testing after six months, the patients with a 
value exceeding the cut-off  value (AR >23%) could be 
consulted to independently perform Brandt-Daroff ’s 
exercises at home to reduce the possibility of vertigi-
nous disturbances recurrence and improve their quality 
of life.
Conclusion
Th e increase in the oVEMP amplitude on the af-
fected side after successful repositioning procedure 
confi rmed the hypothesis on the return of otoconia 
into the area of the utricular macula. We can also con-
clude that of all the VEMP parameters tested, oVEMP 
AR was the only possible signifi cant predictor of the 
future PC-BPPV recurrence.
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Sažetak
ULOGA VESTIBULARNIH EVOCIRANIH MIOGENIH POTENCIJALA 
KAO POKAZATELJA STANJA OPORAVKA KOD BOELSNIKA 
S DOBROĆUDNOM PAROKSIZMALNOM POLOŽAJNOM VRTOGLAVICOM
T. Mendeš, S. Maslovara, A. Včeva i S. Butković Soldo
Okularni vestibularni evocirani mišićni potencijali (oVEMP) i cervikalni VEMP (cVEMP) su novije dijagnostičke me-
tode koje omogućuju uvid u stanje otolitičkih osjetila. Cilj je bio utvrditi postoje li promjene u određenim parametrima 
VEMP valnog kompleksa nakon uspješno provedenog Epleyjeva repozicijskog postupka, koje bi bile pokazatelji stanja opo-
ravka bolesnika s dobroćudnom paroksizmalnom položajnom vrtoglavicom (BPPV). To bi potvrdilo teoriju o povratku 
otolita u područje otolitičkih osjetila. Sekundarni cilj istraživanja bio je utvrditi značenje pojedinih parametara VEMP 
 kompleksa kao prediktora mogućih recidiva bolesti. Ispitivanje je uključilo 48 bolesnika s jednostranim BPPV stražnjega 
polukružnog kanalića. Pri prvom pregledu u sklopu cjelokupne otoneurološke obrade učinjene su im pretrage oVEMP i 
cVEMP. Ovo je ponovljeno i na pregledima kojima su bolesnici pristupili sedam dana i šest mjeseci nakon uspješno prove-
denog Epleyjeva postupka. Pri prvom mjerenju uočeno je značajno smanjenje amplitude oVEMP zahvaćene strane, izraženo 
kroz povećani omjer amplituda. U drugom mjerenju uočen je porast amplitude zahvaćene strane, dok je omjer amplituda 
posljedično smanjen (p=0,693), a statistički značajno smanjen pri završnom pregledu nakon 6 mjeseci (p=0,006). Značajno 
povećanje amplitude oVEMP zahvaćene strane nakon uspješnog repozicijskog postupka potvrđuje hipotezu o povratku 
otolita u području makule utrikulusa.
Ključne riječi: Vestibularni evocirani miogenski potencijali; Otolitna membrana; Benigna paroksizmalna pozicijska vrtoglavica; 
Semicirkularni kanali; Kvaliteta života
